 |
PDBsum entry 4a4x
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Nek2-ede bound to cct248662
|
|
Structure:
|
 |
Serine/threonine-protein kinase nek2. Chain: a. Fragment: catalytic domain, residues 1- 271. Synonym: hspk 21, never in mitosis a-related kinase 2, nima-related protein kinase 2, nima-like protein kinase 1, nek2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008. Expression_system_variant: codonplus rpil
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.207
|
R-free:
|
0.247
|
|
|
Authors:
|
 |
C.Mas-Droux,R.Bayliss
|
|
Key ref:
|
 |
P.Innocenti
et al.
(2012).
Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity.
J Med Chem,
55,
3228-3241.
PubMed id:
|
 |
|
Date:
|
 |
|
20-Oct-11
|
Release date:
|
25-Apr-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P51955
(NEK2_HUMAN) -
Serine/threonine-protein kinase Nek2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
445 a.a.
253 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 8 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
55:3228-3241
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity.
|
|
P.Innocenti,
K.M.Cheung,
S.Solanki,
C.Mas-Droux,
F.Rowan,
S.Yeoh,
K.Boxall,
M.Westlake,
L.Pickard,
T.Hardy,
J.E.Baxter,
G.W.Aherne,
R.Bayliss,
A.M.Fry,
S.Hoelder.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |